Bradford T. Whitmore - 30 Aug 2021 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
10%+ Owner
Signature
Bradford T. Whitmore
Issuer symbol
CLSD
Transactions as of
30 Aug 2021
Net transactions value
-$2,920,427
Form type
4
Filing time
01 Sep 2021, 16:46:18 UTC
Previous filing
04 Aug 2021
Next filing
20 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Sale $702,102 -99,400 -3.5% $7.06* 2,735,941 30 Aug 2021 by Grace Brothers, LP F1, F2
transaction CLSD Common Stock Sale $749,079 -107,682 -3.9% $6.96* 2,628,259 31 Aug 2021 by Grace Brothers, LP F2, F3
transaction CLSD Common Stock Sale $1,469,246 -213,203 -8.1% $6.89* 2,415,056 01 Sep 2021 by Grace Brothers, LP F2, F4
holding CLSD Common Stock 3,529,845 30 Aug 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Bradford T. Whitmore is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.42. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F2 As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,415,056 shares of Common Stock.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.8499 to $7.21. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.66 to $7.09. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.